For advertising Queries please call 9899152321 or email sales@medicaldarpan.com
For advertising Queries please call 9899152321 or email sales@medicaldarpan.com
For advertising Queries please call 9899152321 or email sales@medicaldarpan.com
For advertising Queries please call 9899152321 or email sales@medicaldarpan.com

Blog

2 Feb, 2021
Cipla celebrates 85 years with the launch of its book ‘Caring For Life: The Cipla Story Since 1935’

Mumbai; February 02, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced the lauch of its book ‘Caring For L...
2 Feb, 2021
Lupin Announces Appointment of New Independent Director

Mumbai, India, February 2, 2021: Lupin Limited (Lupin), the global pharmaceutical company, announced the appointment of Mr. Mark D. McDade as an Indep...
25 Jan, 2021
Lupin Receives Approval for Sevelamer Carbonate Tablets

Mumbai, Baltimore, January 25, 2021: Lupin Limited (Lupin), global pharmaceutical company, announced today that it has received approval for its Sevel...
22 Jan, 2021
Alembic Pharmaceuticals announces USFDA Final Approval for Midodrine Hydrochloride Tablets USP, 2.5 mg, 5 mg, and 10 mg

Alembic Pharmaceuticals Limited (Alembic) today announced it has received approval from the US Food & Drug Administration (USFDA) for its Abbrevia...
21 Jan, 2021
Professor Peter Piot Joins the Board of Biocon Biologics Limited as an Independent Director

Biocon Biologics Ltd., a fully integrated ‘pure-play’ biosimilars company and a subsidiary of Biocon Ltd. (BSE code: 532523, NSE: BIOCON), anno...
11 Jan, 2021
Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L

PARIS and CAMBRIDGE, UK – January 11, 2021 – Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal anti...
6 Jan, 2021
Lupin Receives Approval for Sulfamethoxazole and Trimethoprim Oral Suspension USP

Mumbai, Baltimore, January 6, 2021: Lupin Limited (Lupin), global pharmaceutical company, announced today that it has received approval for its Sulfam...
1 Nov, 2020
Swedish temperature monitoring solutions provider, TSS, appoints new regional manager for Middle East & India operations

Swedish provider of temperature monitoring solutions for the life science industry appoints Christopher Hobeiche to oversee its operations in the Midd...
22 Oct, 2020
Helmet Brand Steelbird ventures out Healthcare Business

New Delhi, 20th October, 2020: Asia's largest helmet manufacturer Steelbird Hi-tech India (SBHT) apart from producing its popular range of motorcycle...
22 Oct, 2020
8.50 lac MEMBERS OF AIOCD ARE READY TO SUPPLY COVID VAACINE 

All India Organisation of Chemists and Druggists have Appealed to Prime Minister to utilize established supply chain for vaccine distribution through ...
22 Oct, 2020
Issar Pharma Develops First-ever Peptide Molecule for Skin Care “Mission Molecules”

India’s first-ever peptide molecule for the treatment of Vitiligo was developed way back in 2004 and the second peptide New Chemical Entity (NCE) wh...
28 Aug, 2020
Lupin and Mylan Launch Nepexto®, Biosimilar Etanercept in Germany

Mumbai, India | BAD HOMBURG, Germany, August 26, 2020: Lupin Limited (Lupin) and Mylan N.V. (NASDAQ: MYL) announced today the launch of Nepexto®, ...